PCD logo

Comorbidity Among Adults With Epilepsy — United States, 2021–2022

PEER REVIEWED


Figure.

Percentage of adults with nonpsychiatric chronic conditions, by number of conditions and epilepsy status, National Health Interview Survey, United States, 2021 and 2022. Error bars indicate 95% CIs. Percentage was age standardized by using the 2000 US Census Bureau–projected US adult population with 3 age groups (18‒44 y, 45‒64 y, ≥65 y) (8). Chronic conditions included were hypertension, coronary heart disease, stroke, high cholesterol, diabetes, prediabetes, overweight, obesity, cancer, asthma, chronic obstructive pulmonary disease, arthritis, difficulty remembering or concentrating, dementia, and immunosuppression. Adults with epilepsy (active or inactive) were more likely to report 4 or more chronic conditions than adults without epilepsy.

Percentage of adults with nonpsychiatric chronic conditions, by number of conditions and epilepsy status, National Health Interview Survey, United States, 2021 and 2022. Error bars indicate 95% CIs. Percentage was age standardized by using the 2000 US Census Bureau–projected US adult population with 3 age groups (18‒44 y, 45‒64 y, ≥65 y) (8). Chronic conditions included were hypertension, coronary heart disease, stroke, high cholesterol, diabetes, prediabetes, overweight, obesity, cancer, asthma, chronic obstructive pulmonary disease, arthritis, difficulty remembering or concentrating, dementia, and immunosuppression. Adults with epilepsy (active or inactive) were more likely to report 4 or more chronic conditions than adults without epilepsy.
Epilepsy status Number of chronic conditions % (95% CI)
No history of epilepsy No chronic conditions 16.5 (16.1-17.0)
No history of epilepsy 1 chronic condition 30.0 (29.5-30.5)
No history of epilepsy 2 chronic conditions 19.7 (19.4-20.1)
No history of epilepsy 3 chronic conditions 12.6 (12.3-12.9)
No history of epilepsy ≥4 chronic conditions 21.2 (20.8-21.6)
Any epilepsy No chronic conditions 4.5 (3.0-5.9)
Any epilepsy 1 chronic condition 17.6 (14.4-20.9)
Any epilepsy 2 chronic conditions 20.5 (17.4-23.7)
Any epilepsy 3 chronic conditions 14.4 (11.8-17.0)
Any epilepsy ≥4 chronic conditions 43.0 (39.1-46.8)
Active epilepsy No chronic conditions 3.7 (2.0-5.4)
Active epilepsy 1 chronic condition 16.9 (12.7-21.1)
Active epilepsy 2 chronic conditions 20.5 (16.5-24.6)
Active epilepsy 3 chronic conditions 15.3 (12.0-18.6)
Active epilepsy ≥4 chronic conditions 43.6 (38.9-48.3)
Inactive epilepsy No chronic conditions 5.9 (3.1-8.7)
Inactive epilepsy 1 chronic condition 19.3 (14.1-24.5)
Inactive epilepsy 2 chronic conditions 20.9 (15.8-25.9)
Inactive epilepsy 3 chronic conditions 13.1 (9.0-17.3)
Inactive epilepsy ≥4 chronic conditions 40.9 (34.5-47.2)

Return to Article

Top

Error processing SSI file

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.